Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys
Open Access
- 11 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 11, 599974
Abstract
The membrane attack complex—also known as C5b-9—is the end-product of the classical, lectin, and alternative complement pathways. It is thought to play an important role in the pathogenesis of various kidney diseases by causing cellular injury and tissue inflammation, resulting in sclerosis and fibrosis. These deleterious effects are, consequently, targeted in the development of novel therapies that inhibit the formation of C5b-9, such as eculizumab. To clarify how C5b-9 contributes to kidney disease and to predict which patients benefit from such therapy, knowledge on deposition of C5b-9 in the kidney is essential. Because immunohistochemical staining of C5b-9 has not been routinely conducted and never been compared across studies, we provide a review of studies on deposition of C5b-9 in healthy and diseased human kidneys. We describe techniques to stain deposits and compare the occurrence of deposits in healthy kidneys and in a wide spectrum of kidney diseases, including hypertensive nephropathy, diabetic nephropathy, membranous nephropathy, IgA nephropathy, lupus nephritis, C3 glomerulopathy, and thrombotic microangiopathies such as the atypical hemolytic uremic syndrome, vasculitis, interstitial nephritis, acute tubular necrosis, kidney tumors, and rejection of kidney transplants. We summarize how these deposits are related with other histological lesions and clinical characteristics. We evaluate the prognostic relevance of these deposits in the light of possible treatment with complement inhibitors.Keywords
Funding Information
- Nierstichting
This publication has 226 references indexed in Scilit:
- Two Patients With History of STEC-HUS, Posttransplant Recurrence and Complement Gene MutationsAmerican Journal of Transplantation, 2013
- Assembly and Regulation of the Membrane Attack Complex Based on Structures of C5b6 and sC5b9Cell Reports, 2012
- A Trial of Complement Inhibition in a Patient with Cryoglobulin-Induced GlomerulonephritisCase Reports in Nephrology and Urology, 2012
- Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal functionBMC Nephrology, 2011
- Proliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of ComplementClinical Journal of the American Society of Nephrology, 2011
- Immune Complex-Mediated Complement Activation in a Patient with IgG4-Related Tubulointerstitial NephritisCase Reports in Nephrology and Urology, 2011
- Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2Journal of the American Society of Nephrology, 2010
- Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathwayKidney International, 2009
- Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient miceProceedings of the National Academy of Sciences, 2006
- Using polymerized C9 to produce a monoclonal antibody against a neoantigen of the human terminal complement complex.Journal of Pharmacobio-Dynamics, 1990